BACKGROUND: The ability to image cardiomyocyte (CM) apoptosis in heart failure could facilitate more accurate diagnostics and optimize targeted therapeutics. We thus aimed to develop a platform to image CM apoptosis quantitatively and specifically in heart failure in vivo. The myocardium in heart failure, however, is characterized by very low levels of CM apoptosis and normal vascular permeability, factors thought to preclude the use of molecular MRI. METHODS AND RESULTS: Female mice with overexpression of Gaq were studied. Two weeks postpartum, these mice develop a cardiomyopathy characterized by low levels of CM apoptosis and minimal myocardial necrosis or inflammation. The mice were injected with the annexin-labeled nanoparticle (AnxCLIO-Cy5.5) or a control probe (CLIO-Cy5.5) and imaged in vivo at 9.4 T. Uptake of AnxCLIO-Cy5.5 occurred in isolated clusters, frequently in the subendocardium. Myocardial T2* was significantly lower (7.6+/-1.5 versus 16.8+/-2.7 ms, P<0.05) in the mice injected with AnxCLIO-Cy5.5 versus CLIO-Cy5.5, consistent with the uptake of AnxCLIO-Cy5.5 by apoptotic CMs. A strong correlation (r(2)=0.86, P<0.05) was seen between in vivo T2* (AnxCLIO-Cy5.5 uptake) and myocardial caspase-3 activity. CONCLUSIONS: The ability of molecular MRI to image sparsely expressed targets in the myocardium is demonstrated in this study. Moreover, a novel platform for high-resolution and specific imaging of CM apoptosis in heart failure is established. In addition to providing novel insights into the pathogenesis of CM apoptosis, the developed platform could facilitate the development of novel antiapoptotic therapies in heart failure.
BACKGROUND: The ability to image cardiomyocyte (CM) apoptosis in heart failure could facilitate more accurate diagnostics and optimize targeted therapeutics. We thus aimed to develop a platform to image CM apoptosis quantitatively and specifically in heart failure in vivo. The myocardium in heart failure, however, is characterized by very low levels of CM apoptosis and normal vascular permeability, factors thought to preclude the use of molecular MRI. METHODS AND RESULTS: Female mice with overexpression of Gaq were studied. Two weeks postpartum, these mice develop a cardiomyopathy characterized by low levels of CM apoptosis and minimal myocardial necrosis or inflammation. The mice were injected with the annexin-labeled nanoparticle (AnxCLIO-Cy5.5) or a control probe (CLIO-Cy5.5) and imaged in vivo at 9.4 T. Uptake of AnxCLIO-Cy5.5 occurred in isolated clusters, frequently in the subendocardium. Myocardial T2* was significantly lower (7.6+/-1.5 versus 16.8+/-2.7 ms, P<0.05) in the mice injected with AnxCLIO-Cy5.5 versus CLIO-Cy5.5, consistent with the uptake of AnxCLIO-Cy5.5 by apoptotic CMs. A strong correlation (r(2)=0.86, P<0.05) was seen between in vivo T2* (AnxCLIO-Cy5.5 uptake) and myocardial caspase-3 activity. CONCLUSIONS: The ability of molecular MRI to image sparsely expressed targets in the myocardium is demonstrated in this study. Moreover, a novel platform for high-resolution and specific imaging of CM apoptosis in heart failure is established. In addition to providing novel insights into the pathogenesis of CM apoptosis, the developed platform could facilitate the development of novel antiapoptotic therapies in heart failure.
Authors: Pericle Di Napoli; Alfonso A Taccardi; Alfredo Grilli; Mario Felaco; Angela Balbone; Domenico Angelucci; Sabina Gallina; Antonio M Calafiore; Raffaele De Caterina; Antonio Barsotti Journal: Am Heart J Date: 2003-12 Impact factor: 4.749
Authors: E A Dumont; C P Reutelingsperger; J F Smits; M J Daemen; P A Doevendans; H J Wellens; L Hofstra Journal: Nat Med Date: 2001-12 Impact factor: 53.440
Authors: J Narula; E R Acio; N Narula; L E Samuels; B Fyfe; D Wood; J M Fitzpatrick; P N Raghunath; J E Tomaszewski; C Kelly; N Steinmetz; A Green; J F Tait; J Leppo; F G Blankenberg; D Jain; H W Strauss Journal: Nat Med Date: 2001-12 Impact factor: 53.440
Authors: L Hofstra; I H Liem; E A Dumont; H H Boersma; W L van Heerde; P A Doevendans; E De Muinck; H J Wellens; G J Kemerink; C P Reutelingsperger; G A Heidendal Journal: Lancet Date: 2000-07-15 Impact factor: 79.321
Authors: Catherine Communal; Marius Sumandea; Pieter de Tombe; Jagat Narula; R John Solaro; Roger J Hajjar Journal: Proc Natl Acad Sci U S A Date: 2002-04-23 Impact factor: 11.205
Authors: Mukesh G Harisinghani; Jelle Barentsz; Peter F Hahn; Willem M Deserno; Shahin Tabatabaei; Christine Hulsbergen van de Kaa; Jean de la Rosette; Ralph Weissleder Journal: N Engl J Med Date: 2003-06-19 Impact factor: 91.245
Authors: Denis B Buxton; Melissa Antman; Narasimhan Danthi; Vasken Dilsizian; Zahi A Fayad; Mario J Garcia; Michael R Jaff; Michael Klimas; Peter Libby; Matthias Nahrendorf; Albert J Sinusas; Samuel A Wickline; Joseph C Wu; Robert O Bonow; Ralph Weissleder Journal: Circulation Date: 2011-05-17 Impact factor: 29.690
Authors: Stuart M Grieve; Jacob Lønborg; Jawad Mazhar; Timothy C Tan; Edwin Ho; Chia-Chi Liu; William Lay; Anthony J Gill; Philip Kuchel; Ravinay Bhindi; Gemma A Figtree Journal: Eur Biophys J Date: 2012-09-28 Impact factor: 1.733